SCHEMBL2884117

SCHEMBL2884117

Nc1ccc(Nc2nc(-c3cccc4c3oc3ccccc34)cc3ccnn23)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 1/20 0.36
ALOX5 P09917 2/20 0.35
KMT2A Q03164 8/20 0.34
ALDH1A1 P00352 7/20 0.34
MEN1 O00255 6/20 0.34
MAPT P10636 4/20 0.34
NPC1 O15118 3/20 0.34
RAB9A P51151 3/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
GAA P10253 1/20 0.34
NFKB1 P19838 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34
KDM4E B2RXH2 7/20 0.34
HPGD P15428 5/20 0.34
LMNA P02545 3/20 0.34
HSD17B10 Q99714 3/20 0.34
POLB P06746 3/20 0.34
NPSR1 Q6W5P4 1/20 0.34
PRKDC P78527 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2876562 0.91 MEN1 (0.35) CDK2ALOX5KMT2AALDH1A1MEN1
SCHEMBL2214233 0.91 DNMT1 (0.42) KMT2AALDH1A1MEN1MAPTNPC1
SCHEMBL2884113 0.88 SMN1; SMN2 (0.37) CDK2ALOX5ALDH1A1MAPTNPC1
SCHEMBL2216158 0.85 FADS1 (0.36) CDK2KMT2AALDH1A1MEN1MAPT
SCHEMBL2216183 0.84 ALDH1A1 (0.42) KMT2AALDH1A1MEN1MAPTNPC1
SCHEMBL2876559 0.83 TGFBR1 (0.38) ALOX5KMT2AMEN1NPC1RAB9A
SCHEMBL2215080 0.83 LMNA (0.50) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL2216148 0.83 SMN1; SMN2 (0.39) CDK2KMT2AALDH1A1MEN1MAPT
SCHEMBL2214178 0.82 KDM4E (0.39) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL2215322 0.82 KDM4E (0.37) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7745446-B2 Pyrazolo[1,5-c]pyrimidines BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-06-29 US disclosed
US-20070254046-A1 Novel Pyrazolopyrimidines ALTANA PHARMA AG (DE) 2007-11-01 US disclosed
EP-1797096-A2 NOVEL PYRAZOLOPYRIMIDINES Altana Pharma AG (DE) 2007-06-20 EP disclosed
WO-2006027346-A2 NOVEL PYRAZOLOPYRIMIDINES ALTANA PHARMA AG (DE) 2006-03-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070254046-A1 Novel Pyrazolopyrimidines MCL1, RARS2, CDK4 CDK2 8/4885ALOX5 3694/4885KMT2A 3645/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.